Our People
Uniting people dedicated to improving outcomes for childhood cancer patients through collaborative research and innovation.
Our dedicated team work to advance cancer research and innovation
We unite leading researchers and clinicians and support their efforts to deliver breakthrough research that will ultimately help every child with cancer to survive and thrive.
Children's Cancer CoLab brings together a team of dedicated professionals who share a common goal: to improve outcomes for our youngest cancer patients through collaborative research and innovation.
Our highly esteemed Board of Directors, led by Prof Brendan Murphy AC, provides Children’s Cancer CoLab with deep scientific and clinical knowledge as well as expertise from sectors covering commercialisation, healthcare, government, not-for-profits and finance.
Our small management team, led by Dr Udani Reets, provides expertise spanning medical research and innovation, commercialisation, partnerships, impact strategy, strategic communications, finance and governance.
Our Board and management team are committed to our mission of improving outcomes for our youngest cancer patients by accelerating collaborative research and innovation into the clinic. We believe that by working together and challenging traditional boundaries, we can make a significant difference in the lives of young cancer patients and their families in Australia and globally.
Our Board of Directors
Our Board of Directors offers expert guidance and governance to advance our collaborative mission.
Our Team
Meet the people behind the mission, helping Children’s Cancer CoLab to transform childhood cancer outcomes.
Our Experts
Combining scientific rigour with clinical insights to guide impactful childhood cancer research and innovation.
More ways you can make an impact
Your support drives critical research and innovation that will change lives. By supporting Children's Cancer CoLab, you become part of a community working to ensure every young patient with cancer survives and thrives. Our approach unites top researchers across disciplines and institutions, breaking traditional barriers to accelerate discoveries from the lab to clinic, creating real impact for young cancer patients and their families.
